Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Obesity - Management
View full scenario

What are the criteria for starting orlistat?

  • Orlistat is licensed for adults aged between 18 and 75 years who meet one of the following criteria:
    • Body mass index (BMI) greater than or equal to 30 kg/m2, or
    • BMI greater than or equal to 28 kg/m2 with comorbidities.

In depth

Who should avoid taking orlistat?

  • Do not prescribe orlistat for someone with a chronic malabsorption syndrome or cholestasis.

In depth

What important interactions are associated with orlistat?

  • Fat-soluble vitamins or multivitamin supplements: if needed, they should be given at least 2 hours after a dose of orlistat or at bedtime.
  • Ciclosporin: if concomitant use is unavoidable, monitor ciclosporin levels frequently, especially when starting or stopping orlistat.
  • Warfarin: monitor international normalized ratio (INR) closely, especially when starting or stopping orlistat.
  • Levothyroxine: consider giving at least 2 hours after a dose of orlistat or at bedtime.
  • Antiepileptic drugs: consider giving at least 2 hours after a dose of orlistat or at bedtime.

In depth

Can orlistat be used during pregnancy and breastfeeding?

  • Orlistat is not recommended for use during pregnancy.
  • Orlistat is contraindicated during breastfeeding.

In depth

What adverse effects are associated with orlistat?

  • Gastrointestinal adverse effects are common (e.g. oily spotting, abdominal discomfort, faecal urgency, fatty stools). These usually reduce with continued use of orlistat and can often be reduced by limiting fat intake.

In depth

What advice should I give to someone who has been prescribed orlistat?

  • Take orlistat immediately before, during, or up to 1 hour after each main meal (up to a maximum of three times a day).
  • Omit the dose of orlistat if a meal is missed, or if the meal contains little or no fat.
  • If a woman who is taking an oral contraceptive experiences severe diarrhoea whilst taking orlistat, advise her to use an additional method of contraception.

In depth

For how long should treatment with orlistat continue?

  • Only continue orlistat beyond 3 months if the person has lost at least 5% of their body weight, as measured at the start of drug treatment.
  • There is no restriction on how long orlistat may be prescribed. After 12 months, a decision to continue treatment should be taken on an individual basis, weighing up the benefits, costs, and risks for that person. Review at regular intervals.

In depth

Prescriptions

Orlistat

Age from 18 to 75 years
Orlistat capsules: 120mg three times a day
Orlistat 120mg capsules
Take one capsule with each main meal. Maximum of 3 capsules in 24 hours. (Take each capsule just before, during, or up to 1 hour after a main meal.)
Supply 84 capsules.
Age: from 18 years to 75 years
NHS cost: £33.58
Licensed use: yes
Patient information: It is important that you still keep to your diet, and try to keep exercising, even though you have been prescribed orlistat. Make sure that you eat plenty of fruit and vegetables as part of your diet. Do not take a capsule if you miss a main meal, or the meal does not contain fat. Orlistat may cause urgent or increased need to open the bowels, flatulence with discharge, oily discharge, and oily or fatty stools. Limiting the fat in your diet will reduce these side effects. If you are taking multivitamins, do not take them during the 2 hours before, or the 2 hours after taking orlistat.

© NHS Institute for Innovation and Improvement